Breast cancer HER2 scoring agreement study: pathologists vs. pathologists and AI, showing AI-measured intra-sample heterogeneity is linked to lower agreement

Analysis of pathologists’ intraobserver, interobserver and AI agreement in breast cancer HER2 scoring: AI-assessed intra-sample tumor heterogeneity relates to lower agreement among pathologists and with AI

Conference

AACR AI and Machine Learning  2025